By Steven Chen, chief medical Officer at medtech firm ImpediMed. As cancer survival rates continue to climb, healthcare providers must address a critical yet often overlooked...
The 2024 Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) has published new guidelines that integrate cutting-edge international research with Chinese clinical evidence – including...
Pharma giant Novartis and Danish digital health firm Dawn Health have teamed up to develop a new app to support breast cancer patients. Cora BC provides...
The search for more effective treatments for deadly metaplastic breast cancer has uncovered two drugs with the potential to interrupt disease progression. US researchers examined the...
Telephone-delivered acceptance and commitment therapy (ACT) is beneficial for reducing fatigue’s interference with functioning and improves the quality of life for survivors of metastatic breast cancer,...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and...
A new study underscores the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. A test based on the detection...
A treatment for breast cancer-related vasomotor symptoms (VMS) – known as hot flashes – has seen positive Phase 3 trial results in women with breast cancer or...
Researchers have developed a non-invasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects using localised magnetic fields. By applying brief, localised...
